230 related articles for article (PubMed ID: 10080950)
21. Alpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo.
Yamamoto H; Oviedo A; Sweeley C; Saito T; Moskal JR
Cancer Res; 2001 Sep; 61(18):6822-9. PubMed ID: 11559557
[TBL] [Abstract][Full Text] [Related]
22. Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
Biochemistry; 2011 Nov; 50(44):9475-87. PubMed ID: 21913655
[TBL] [Abstract][Full Text] [Related]
23. Involvement of cell surface glycans in adhesion of human colon carcinoma cells to liver tissue in a frozen section assay: role of endo-beta-galactosidase-sensitive structures.
Ota M; Takamura N; Irimura T
Cancer Res; 2000 Sep; 60(18):5261-8. PubMed ID: 11016656
[TBL] [Abstract][Full Text] [Related]
24. Linkage-specific action of endogenous sialic acid O-acetyltransferase in Chinese hamster ovary cells.
Shi WX; Chammas R; Varki A
J Biol Chem; 1996 Jun; 271(25):15130-8. PubMed ID: 8662976
[TBL] [Abstract][Full Text] [Related]
25. Specific detection of sialyl Lewis X determinant carried on the mucin GlcNAcbeta1-->6GalNAcalpha core structure as a tumor-associated antigen.
Kumamoto K; Mitsuoka C; Izawa M; Kimura N; Otsubo N; Ishida H; Kiso M; Yamada T; Hirohashi S; Kannagi R
Biochem Biophys Res Commun; 1998 Jun; 247(2):514-7. PubMed ID: 9642161
[TBL] [Abstract][Full Text] [Related]
26. TNF regulates sialyl-Lewisx and 6-sulfo-sialyl-Lewisx expression in human lung through up-regulation of ST3GAL4 transcript isoform BX.
Colomb F; Krzewinski-Recchi MA; El Machhour F; Mensier E; Jaillard S; Steenackers A; Harduin-Lepers A; Lafitte JJ; Delannoy P; Groux-Degroote S
Biochimie; 2012 Sep; 94(9):2045-53. PubMed ID: 22691873
[TBL] [Abstract][Full Text] [Related]
27. beta 1,3-Galactosyltransferase beta 3Gal-T5 acts on the GlcNAcbeta 1-->3Galbeta 1-->4GlcNAcbeta 1-->R sugar chains of carcinoembryonic antigen and other N-linked glycoproteins and is down-regulated in colon adenocarcinomas.
Salvini R; Bardoni A; Valli M; Trinchera M
J Biol Chem; 2001 Feb; 276(5):3564-73. PubMed ID: 11058588
[TBL] [Abstract][Full Text] [Related]
28. ST3Gal III modulates breast cancer cell adhesion and invasion by altering the expression of invasion-related molecules.
Cui HX; Wang H; Wang Y; Song J; Tian H; Xia C; Shen Y
Oncol Rep; 2016 Dec; 36(6):3317-3324. PubMed ID: 27779707
[TBL] [Abstract][Full Text] [Related]
29. An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.
Burchell J; Poulsom R; Hanby A; Whitehouse C; Cooper L; Clausen H; Miles D; Taylor-Papadimitriou J
Glycobiology; 1999 Dec; 9(12):1307-11. PubMed ID: 10561455
[TBL] [Abstract][Full Text] [Related]
30. E-selectin: sialyl Lewis, a dependent adhesion of colon cancer cells, is inhibited differently by antibodies against E-selectin ligands.
Srinivas U; Påhlsson P; Lundblad A
Scand J Immunol; 1996 Sep; 44(3):197-203. PubMed ID: 8795712
[TBL] [Abstract][Full Text] [Related]
31. alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.
Pérez-Garay M; Arteta B; Pagès L; de Llorens R; de Bolòs C; Vidal-Vanaclocha F; Peracaula R
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824144
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of UDP-galactose transporter messenger RNA in human colon cancer tissues and its implication in synthesis of Thomsen-Friedenreich antigen and sialyl Lewis A/X determinants.
Kumamoto K; Goto Y; Sekikawa K; Takenoshita S; Ishida N; Kawakita M; Kannagi R
Cancer Res; 2001 Jun; 61(11):4620-7. PubMed ID: 11389099
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells.
Carvalho AS; Harduin-Lepers A; Magalhães A; Machado E; Mendes N; Costa LT; Matthiesen R; Almeida R; Costa J; Reis CA
Int J Biochem Cell Biol; 2010 Jan; 42(1):80-9. PubMed ID: 19781661
[TBL] [Abstract][Full Text] [Related]
34. CD22-mediated cell adhesion to cytokine-activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins.
Hanasaki K; Varki A; Powell LD
J Biol Chem; 1995 Mar; 270(13):7533-42. PubMed ID: 7706300
[TBL] [Abstract][Full Text] [Related]
35. Endothelial alpha 2,6-linked sialic acid inhibits VCAM-1-dependent adhesion under flow conditions.
Abe Y; Smith CW; Katkin JP; Thurmon LM; Xu X; Mendoza LH; Ballantyne CM
J Immunol; 1999 Sep; 163(5):2867-76. PubMed ID: 10453033
[TBL] [Abstract][Full Text] [Related]
36. Expression of beta-galactoside alpha 2,6-sialyltransferase does not alter the susceptibility of human colon cancer cells to NK-mediated cell lysis.
Dall'Olio F; Mariani E; Tarozzi A; Meneghetti A; Chiricolo M; Lau JT; Facchini A
Glycobiology; 1997 Jun; 7(4):507-13. PubMed ID: 9184831
[TBL] [Abstract][Full Text] [Related]
37. Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells.
Izumi Y; Taniuchi Y; Tsuji T; Smith CW; Nakamori S; Fidler IJ; Irimura T
Exp Cell Res; 1995 Jan; 216(1):215-21. PubMed ID: 7529188
[TBL] [Abstract][Full Text] [Related]
38. ST3Gal-4 is the primary sialyltransferase regulating the synthesis of E-, P-, and L-selectin ligands on human myeloid leukocytes.
Mondal N; Buffone A; Stolfa G; Antonopoulos A; Lau JT; Haslam SM; Dell A; Neelamegham S
Blood; 2015 Jan; 125(4):687-96. PubMed ID: 25498912
[TBL] [Abstract][Full Text] [Related]
39. Characterization of cancer associated mucin type O-glycans using the exchange sialylation properties of mammalian sialyltransferase ST3Gal-II.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
J Proteome Res; 2012 Apr; 11(4):2609-18. PubMed ID: 22329400
[TBL] [Abstract][Full Text] [Related]
40. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
